{"componentChunkName":"component---src-templates-chapter-level-1-chapter-level-1-tsx","path":"/topics/insulin-therapy-in-type-2-diabetes/management/","result":{"pageContext":{"chapter":{"id":"8cb52e25-e560-555c-9e28-b8aa54455a25","slug":"management","fullItemName":"Management","depth":1,"htmlHeader":"<!-- begin field 5acb8d22-9a3c-44db-a396-abfd9542c35f --><h1>Management</h1><!-- end field 5acb8d22-9a3c-44db-a396-abfd9542c35f -->","summary":null,"htmlStringContent":"<!-- begin item 7783d2b8-06c9-4296-ba42-78ee008a6bc0 --><!-- end item 7783d2b8-06c9-4296-ba42-78ee008a6bc0 -->","topic":{"id":"67fc9a6c-6820-57fe-9097-e58e4a920884","topicId":"88119743-0abc-4e8b-8f25-e4fc3f538484","topicName":"Insulin therapy in type 2 diabetes","slug":"insulin-therapy-in-type-2-diabetes","lastRevised":"Last revised in January 2021","chapters":[{"id":"4f9882ba-20c0-5e9e-bb3a-2155b58e9fa3","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"389303c3-3ee2-5555-ae0c-a591f93d77cc","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"514165fe-0c20-5522-a4e0-11c24b147228","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"bc06b7e7-e2fe-54d4-88af-3eb1d924ea47","slug":"changes","fullItemName":"Changes"},{"id":"ef37d0a0-9664-5b62-b330-ad962b4b3a68","slug":"update","fullItemName":"Update"}]},{"id":"a5f3d9b7-224a-5eea-989b-9a0cbacf5225","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"f2bce4cb-bcce-5ce9-996d-2ced6ac3a50a","slug":"goals","fullItemName":"Goals"},{"id":"6455faf7-803e-54c2-8dd1-2cbbd74a5d85","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"cf13482a-90e2-55e5-9af9-b7d5293d52ac","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"3d065be5-2b02-510f-9371-5b67f3ccc4a3","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"bd7fd90b-c79f-59b8-9faf-deb57545cee3","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"d6ece006-e4c1-51be-bb8b-c25c0677c4ca","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"43e27bd2-a6b7-552a-b13d-c83d6f3d0236","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"578c4a95-b0c0-57ab-9331-874d0bc55f06","slug":"what-is-insulin","fullItemName":"What is insulin?"}]},{"id":"8cb52e25-e560-555c-9e28-b8aa54455a25","fullItemName":"Management","slug":"management","subChapters":[{"id":"e1e64ce2-2b3e-5b6c-81d3-e0bb4541d132","slug":"insulin-therapy-type-2-diabetes","fullItemName":"Scenario: Insulin therapy - type 2 diabetes"}]},{"id":"52a8abf6-b1aa-55a4-b678-dec7383f5683","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"0589e653-130e-5d79-9918-c4d6981bca94","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"0274003c-a029-5e95-add6-16cb7afbee51","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"43dcfc3e-f5f4-5f31-b9cf-8af2f3f255be","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"8ace3fa1-6c91-5ca6-b45a-a561f03342a4","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"1a572d4a-4179-5fbe-8d18-4a37c55e2078","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"ed27f179-49b6-5ae8-a5bf-c2d6fdc0cb4c","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"11154307-c719-57fb-8971-db931a520f7c","fullItemName":"References","slug":"references","subChapters":[]}]},"subChapters":[{"id":"e1e64ce2-2b3e-5b6c-81d3-e0bb4541d132","slug":"insulin-therapy-type-2-diabetes","fullItemName":"Scenario: Insulin therapy - type 2 diabetes","summary":"Covers general information on insulin therapy for people with type 2 diabetes."}]}}},"staticQueryHashes":["3666801979"]}